BlackRock Institutional Trust’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$4.75M Buy
210,687
+4,111
+2% +$99.2K ﹤0.01% 2748
2016
Q3
$4.73M Sell
206,576
-95
-0% -$2.12K ﹤0.01% 2716
2016
Q2
$4.42M Sell
206,671
-6,372
-3% -$201K ﹤0.01% 2738
2016
Q1
$7.32M Buy
213,043
+4,007
+2% +$106K ﹤0.01% 2466
2015
Q4
$5.75M Buy
209,036
+31,472
+18% +$861K ﹤0.01% 2639
2015
Q3
$5.31M Buy
177,564
+55,768
+46% +$1.83M ﹤0.01% 2681
2015
Q2
$5.13M Buy
121,796
+114,941
+1,677% +$5.43M ﹤0.01% 2763
2015
Q1
$343K Buy
+6,855
New +$333K ﹤0.01% 3568

Other funds holding ATEX

BlackRock Institutional Trust's ATEX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Anterix (ATEX) stake by 2% in Q4 2016, buying an estimated $99.2K and bringing the position to 210,687 shares worth $4.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2748.

BlackRock Institutional Trust first reported a position in ATEX in Q1 2015 and has held it in 8 quarters since. The position peaked at $7.32M in Q1 2016. 55 funds tracked by Wall St. Rank hold ATEX as of Q4 2016.

  • BlackRock Institutional Trust held 210,687 shares of Anterix worth $4.75M as of Q4 2016.
  • BlackRock Institutional Trust bought 4,111 Anterix shares in Q4 2016, an estimated $99.2K.
  • Anterix made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2748 holding.
  • BlackRock Institutional Trust first reported a position in Anterix in Q1 2015 and has held it in 8 quarters since.
  • BlackRock Institutional Trust's Anterix position peaked at $7.32M in Q1 2016.
  • 55 funds tracked by Wall St. Rank held Anterix as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.